Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6404590 | 0.86 | ALDH1A1 (0.77) | GAATSHRLMNAALDH1A1NPSR1 | |
| SCHEMBL6404862 | 0.86 | GAA (0.63) | GAATSHRLMNAALDH1A1NPSR1 | |
| SCHEMBL4203989 | 0.85 | SMN1; SMN2 (0.76) | GAATSHRLMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL14427600 | 0.84 | MAPK1 (0.71) | GAALMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL14478973 | 0.83 | MAPK1 (0.72) | GAATSHRLMNAALDH1A1NPSR1 | |
| SCHEMBL18556534 | 0.81 | RAB9A (0.69) | GAATSHRLMNAALDH1A1NPSR1 | |
| SCHEMBL18559305 | 0.81 | RAB9A (0.60) | GAATSHRLMNAALDH1A1NPSR1 | |
| SCHEMBL4211607 | 0.76 | ALDH1A1 (0.76) | GAATSHRLMNAALDH1A1NPSR1 | |
| SCHEMBL13856842 | 0.76 | TDP1 (0.57) | GAALMNAALDH1A1NPSR1KDM4E | |
| SCHEMBL18556533 | 0.75 | TSHR (1.00) | GAATSHRLMNAALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | AGRIUS GROUP, LLC. | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | ABCG2, ATP5ME, DNTT | GAA 85/4885TSHR 3470/4885LMNA 4116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.